These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28592786)

  • 1. Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification.
    Kim HJ; Ko YH; Kim JE; Lee SS; Lee H; Park G; Paik JH; Cha HJ; Choi YD; Han JH; Huh J;
    J Pathol Transl Med; 2017 Jul; 51(4):352-358. PubMed ID: 28592786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV-Related Lymphoproliferative Diseases: A Review in Light of New Classifications.
    Tralongo P; Bakacs A; Larocca LM
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024042. PubMed ID: 38882456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-associated lymphoproliferative disorders: classification and treatment.
    Carbone A; Gloghini A; Dotti G
    Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ hybridisation for Epstein-Barr virus as a differential diagnostic tool for T- and natural killer/T-cell lymphomas in non-immunocompromised patients.
    Chuang SS
    Pathology; 2014 Dec; 46(7):581-91. PubMed ID: 25393247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficiency-Associated Epstein-Barr Virus-Positive B-cell Lymphoproliferative Disorders: A Review and New Paradigm.
    Chapman J
    Surg Pathol Clin; 2023 Jun; 16(2):213-231. PubMed ID: 37149357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of Epstein-Barr Virus-Infected Lymphocyte Cell Types in Peripheral Blood Mononuclear Cells as a Valuable Diagnostic Tool in Hematological Diseases.
    Zhang P; Zeng C; Cheng J; Zhou J; Gu J; Mao X; Zhang W; Cao Y; Luo H; Xu B; Li Q; Xiao M; Zhou J
    Open Forum Infect Dis; 2019 May; 6(5):ofz171. PubMed ID: 31065564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders.
    Yang X; Nishida N; Zhao X; Kanegane H
    Iran J Allergy Asthma Immunol; 2015 Oct; 14(5):462-71. PubMed ID: 26742434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epstein-Barr virus infection and lymphoproliferative disorders].
    Isobe Y
    Rinsho Ketsueki; 2020; 61(9):1286-1296. PubMed ID: 33162528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and management of EBV-positive lymphoproliferative disorders].
    Arai A
    Rinsho Ketsueki; 2023; 64(8):764-771. PubMed ID: 37673629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
    Natkunam Y; Gratzinger D; Chadburn A; Goodlad JR; Chan JKC; Said J; Jaffe ES; de Jong D
    Blood; 2018 Nov; 132(18):1871-1878. PubMed ID: 30082493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
    Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
    Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
    Hue SS; Oon ML; Wang S; Tan SY; Ng SB
    Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.
    Shimoyama Y; Oyama T; Asano N; Oshiro A; Suzuki R; Kagami Y; Morishima Y; Nakamura S
    J Clin Exp Hematop; 2006 Mar; 46(1):1-4. PubMed ID: 17058802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Advances in EBV Related Lymphoproliferative Diseases.
    Lv K; Yin T; Yu M; Chen Z; Zhou Y; Li F
    Front Oncol; 2022; 12():838817. PubMed ID: 35515118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
    Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
    Front Pediatr; 2019; 7():71. PubMed ID: 30931288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.
    Neparidze N; Lacy J
    Clin Adv Hematol Oncol; 2014 Jun; 12(6):358-71. PubMed ID: 25003566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a review.
    Marques-Piubelli ML; Salas YI; Pachas C; Becker-Hecker R; Vega F; Miranda RN
    Pathology; 2020 Jan; 52(1):40-52. PubMed ID: 31706670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency.
    Satou A; Nakamura S
    Cancer Med; 2021 Oct; 10(19):6777-6785. PubMed ID: 34387382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.